Many SARS-CoV-2 variants with naturally acquired mutations have emerged. These
mutations can affect viral properties such as infectivity and immune resistance. Although the …

Over the past 2 years, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
caused the coronavirus disease 2019 (COVID-19) and rapidly spread worldwide. In the …

The 501Y. V2 variants of SARS-CoV-2 containing multiple mutations in spike are now
dominant in South Africa and are rapidly spreading to other countries. Here, experiments …

The SARS-CoV-2 virus, the pathogen causing COVID-19, has caused more than 200 million
confirmed cases, resulting in more than 4.5 million deaths worldwide by the end of August …

Emerging mutations in SARS-CoV-2 cause several waves of COVID-19 pandemic. Here we
investigate the infectivity and antigenicity of ten emerging SARS-CoV-2 variants—B. 1.1 …

ABSTRACT The highly mutated BA. 2.86, with over 30 spike protein mutations in
comparison to Omicron BA. 2 and XBB. 1.5 variants, has raised concerns about its potential …

As the COVID-19 is still growing throughout the globe, a thorough investigation into the
specific immunopathology of SARS-CoV-2, its interaction with the host immune system and …

As of November 2021, several SARS‐CoV‐2 variants appeared and became dominant
epidemic strains in many countries, including five variants of concern (VOCs) Alpha, Beta …

The SARS-CoV-2 lambda variant (lineage C. 37) was designated by the World Health
Organization as a variant of interest and is currently increasing in prevalence in South …

The emerging new VOC B. 1.1. 529 (Omicron) variant has raised serious concerns due to
multiple mutations, reported significant immune escape, and unprecedented rapid …